RE:RE:RE:RE:RE:We will survive ?Thanks RoyMax123 for the clarifications regarding the initial investment by Animalcare, I got my secnd sets of #'s froma KNE press release, anyway, it looks better when using 5M...:)
There is some nice catalysts coming our way that could help them getting some cash flow, they are;
1. Coactiv+ sales picking-up in the USA (they are having some issues at their manufacturing sub-contractor site that should get resolved late Q3);
2. Improvement in pet products sales -- Animalcare mentioned in their last report that Plaqtiv+ is off to a good start. They also have a specific website for this product -- see link:
Plaqtiv+ 3. Skout's -- no news yet but they must be close to be ready to launch their product line;
4. As you noted, dermatology could become a real factor here since this type of product can be sold OTC and have quick market penetration should you pick the right path to market.
Anyway, I like KNE management and how this story is unfolding despite the fact that it happens a little too slowly.
GLTA